Tamara Denner
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 10
- Oncology 9
- Cancer Immunotherapy and Biomarkers 9
- Journals
- Nature (6 papers)Nature Cancer (4 papers)Nature Medicine (3 papers)Nature Genetics (3 papers)Nature Communications (2 papers)
- Partner nations
- United Kingdom
In The Last Decade
Tamara Denner
23 papers receiving 3.8k citations
Tamara Denner's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 2k
- Cancer Research 709
- Immunology 632
- Pulmonary and Respiratory Medicine 606
- Health, Toxicology and Mutagenesis 172
Countries citing papers authored by Tamara Denner
This map shows the geographic impact of Tamara Denner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Denner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Denner more than expected).
Fields of papers citing papers by Tamara Denner
This network shows the impact of papers produced by Tamara Denner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Denner. The network helps show where Tamara Denner may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution Hit paper breakdown → | 2017 | 1030 |
| 2 | Lung adenocarcinoma promotion by air pollutants Hit paper breakdown → | 2023 | 546 |
| 3 | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Hit paper breakdown → | 2018 | 510 |
| 4 | 2017 | 369 | |
| 5 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 268 |
| 6 | The evolution of lung cancer and impact of subclonal selection in TRACERx Hit paper breakdown → | 2023 | 192 |
| 7 | The evolution of non-small cell lung cancer metastases in TRACERx Hit paper breakdown → | 2023 | 159 |
| 8 | Genomic–transcriptomic evolution in lung cancer and metastasis Hit paper breakdown → | 2023 | 140 |
| 9 | 2021 | 114 | |
| 10 | 2022 | 93 | |
| 11 | 2023 | 90 | |
| 12 | 2020 | 75 | |
| 13 | 2023 | 72 | |
| 14 | Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma Hit paper breakdown → | 2025 | 65 |
| 15 | 2021 | 51 | |
| 16 | 2024 | 29 | |
| 17 | 2024 | 29 | |
| 18 | 2024 | 27 | |
| 19 | 2024 | 23 | |
| 20 | 2025 | 15 |
About Tamara Denner
Tamara Denner is a scholar working on Cancer Research, Oncology, Immunology, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 23 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), T-cell and B-cell Immunology (3 papers), Lung Cancer Treatments and Mutations (2 papers), Epigenetics and DNA Methylation (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Nutrition and Health in Aging (1 paper) and Air Quality and Health Impacts (1 paper). The work is most often cited by research in Oncology (2k citations), Cancer Research (709 citations), Immunology (632 citations), Pulmonary and Respiratory Medicine (606 citations) and Health, Toxicology and Mutagenesis (172 citations). Tamara Denner has collaborated with scholars based in United Kingdom. Their work appears in journals such as Nature, Nature Cancer, Nature Medicine, Nature Genetics and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.